InMode Ltd.
Every calculator, already run for INMD
Open the full toolkit →You have the numbers on INMD. Get the argument.
A written report on which of these readings actually decide the outcome for InMode Ltd., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
5 analysts covering INMDAnalyst Price Target Disagreement for InMode Ltd.
Wall Street's bull case implies +18% from the current price; the bear case implies +4%. Analysts are relatively aligned on INMD's range.
Ownership & short interest
Insider Trading Activity for INMD
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including perman…
INMD — frequently asked
Is INMD a buy right now?
Wall Street's consensus rating on InMode Ltd. is none across 5 analysts, with a mean price target of $16.17 (+12% vs. the current $14.45). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is INMD overvalued?
INMD trades at 11.9x trailing earnings, against a DCF fair value of $10 per share. The current price implies 12% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is INMD's next earnings date?
InMode Ltd. is next scheduled to report earnings around Nov 4, 2026. A full INMD research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for InMode Ltd.?
Analysts covering InMode Ltd. (INMD) range from a bear-case target of $15.00 to a bull-case high of $17.00, with a mean consensus target of $16.17 across 3 analysts. The spread of $2.00 (14% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare InMode Ltd. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For InMode Ltd.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full INMD research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on InMode Ltd., in minutes. 3 free reports included with every account — no credit card required.